Clinical Trial Update: Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating palbociclib for metastatic HER2-positive breast cancer with brain metastases; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases of Breast Cancer
• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Northwestern University | Conditions: Breast Carcinoma Metastatic in the Brain, Estrogen Receptor Negative | Phase 2 | Status: TERMINATED | Results posted: 2020-02-24